Tropomyosin as a regulator of cancer cell transformation

Advances in Experimental Medicine and Biology

Volumn 644, Issue , 2008, Pages 124-131

  Helfman, David M ^a   Flynn, Patrick ^a   Khan, Protiti ^a   Saeed, Ali ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ISOPROTEIN; TROPOMYOSIN; TUMOR MARKER;

ANIMAL; BIOLOGICAL MODEL; CANCER INVASION; CELL LINE; CELL MOTION; CELL TRANSFORMATION; CHEMISTRY; CYTOSKELETON; HUMAN; METABOLISM; METASTASIS; NEOPLASM; REVIEW; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETON; HUMANS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; TROPOMYOSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 60849126725     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-85766-4_10     Document Type: Article

References (62)

1. Pollack R, Osborn M, Weber K. Patterns of organization of actin and myosin in normal and transformed cultured cells. Proc Natl Acad Sci USA 1975; 72:994-998.
2. Goldman RD, Yerna MI, Schloss IA. Localization and organization of microfilaments and related proteins in normal and virus-transformed cells. J Supramolecular Struct 1976; 5:155-183. (Pubitemid 8031895)
3. Wang H, Goldberg AR. Changes in microfilament organization and surface topography upon transformation of chick embryo fibroblasts with rous sarcoma virus. Proc Natl Acad Sci USA 1976; 73:4065-4069.
4. Edelman G, Yahara I. Temperature-sensitive changes in surface modulating assemblies of fibroblasts transformed by mutants of Rous sarcoma virus. Proc Natl Acad Sci USA 1976; 73:2047-2051.
5. Vollett JJ, Brugge JS, Noonan CA et al. The role of SV40 gene A in the alteration of microfilaments in transformed cells. Exp Cell Res 1977; 105:119-126. (Pubitemid 8066454)
6. Shin S, Freedman VH, Risser R et al. Tumorigenicty of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci USA 1975; 72:4435-4439.
7. Hendricks M, Weintraub H. Tropomyosin is decreased in transformed cells. Proc Natl Acad Sci USA 1981; 78:5633-5637. (Pubitemid 12245204)
8. Hendicks M, Weintraub H. Multiple tropomyosin polypeptides in chicken embryo fibroblasts: differential repression of transcription by Rous sarcoma virus transformation. Mol Cell Biol 1984; 4:1823-1833. (Pubitemid 14008293)
9. Leonardi CL, Warren RH, Rubin RW. Lack of tropomyosin correlates with the absence of stress fibers in transformed rat kidney cells. Biochem Biophys Acta 1982; 720:154-162. (Pubitemid 12127698)
10. Matsumura F, Lin JJC, Yamashiro-Matsumura S et al. Differential expression of tropomyosin froms in the microfilaments isolated from normal and transformed rat cultured cells. J Biol Chem 1983; 258:13954-13964. (Pubitemid 14203804)
11. Cooper HL, Feuerstain N, Noda M et al. Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes. Mol Cell Biol 1985; 5:972-983. (Pubitemid 15110285)
12. Lin JHC, Helfman DM, Hughes SH et al. Tropomyosin isoforms in chicken embryo fibroblasts: purification, characterization and changes in Rous sarcoma virus-transformed cells. J Cell Biol 1985; 100:692-703. (Pubitemid 15135328)
13. Leavitt I, Latter G, Lutomski L et al. Tropomyosin isoforms switching in tumorigenic human fibroblasts Mol Cell Biol 1986; 6:2721-2726.
14. Takenaga K, Nakamura Y, Sakiyama S. Differential expression of a tropomyosin isoforms in low- and high-metastatic Lewis lung carcinoma cells. Mol cell Biol 1988; 8:3934-3937.
15. Takenaga K, Nakamura Y, Sayiyama S. Suppresion of synthesis of tropomyosin isoforms 2 in metastatic v-Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun 1988; 157:1111-1116. (Pubitemid 19025971)
16. Stehn JR, Schevzov G, O'Neill GM et al. Specialisation of the tropomyosin composition of actin filaments provides new potential targets for chemotherapy. Current Cancer Drug Targets 2006; 6:245-256. (Pubitemid 43764743)
17. Franzen B, Linder S, Uryu K et al. Expression of tropomyosin isosforms in benign and malignant human breast lesions. Brit J Cancer 1996; 73:909-913. (Pubitemid 26110162)
18. Raval GN, Bharadwaj S, Levine EA et al. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. Oncogene 2003; 22:6194-6203. (Pubitemid 37281649)
19. Varga AE, Stourman NV, Zheng Q et al. Silencing of the tropomyosin-1 gene by DNA methylation alters tumor suppressor function of TGF-beta. Oncogene 2005; 24:5043-5052. (Pubitemid 41129082)
20. Pawlak G, McGarvey TW, Nguyen TB et al. Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder. Int J Cancer 2004; 110:368-373. (Pubitemid 38649887)
21. Hughes JA, Cook-Yarborough CM, Chadwick NC et al. High-molecular-weight tropomyosins localize to the contractile rings of dividing CNS cells but are absent from malignant pedoatric and adult CNS tumors. Glia 2003; 42:25-35. (Pubitemid 36427418)
22. Galloway PG, Likavec MJ, Perry G. Tropomyosin isoforms expression in normal and neoplastic astrocytes. Lab Invest 1990; 62:163-170. (Pubitemid 20108291)
23. Lin JL, Geng X, Bhattacharya SD et al. Isolation and sequencing of a novel tropomyosin isoforms preferentially associated with colon cancer. Gastroenterology 2002; 123:152-162. (Pubitemid 34747536)
24. Katz ME, McCormick F. Signal transduction from multiple Ras effectors. Curr Opin Genet Dev 1997; 7:75-79. (Pubitemid 27092767)
25. Shields JM, Pruitt K, McFall A et al. Understanding Ras: it ain't over 'til it's over. Trends Cell Biol 2000; 10:147-154.
26. Janssen RAJ, Veenstra KG, Jonasch P et al. Ras- and Raf-induced down-modulation of nonmuscle tropomyosin are MEK-independent. J Biol Chem 1998; 273:32182-32186. (Pubitemid 29177164)
27. Kim PN, Jonasch E, Mosterman BC et al. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade. Cell Growth Differ 2001; 12:543-550. (Pubitemid 33095577)
28. Janssen RAJ, Kim PN, Mier JW et al. Overexpression of kinase suppressor of Ras upregulates the high-molecular weight tropomyosin isoforms in ras-transformed NIH 3T3 fibroblasts. Mol Cell Biol 2003; 23:1786-1797. (Pubitemid 36246058)
29. Ljungdahl S, Linder S, Franzen B et al. Down-regulation of tropomyosin-2 expression in c-Jun-transformed rat fibroblasts involves induction of a MEK-1 dependent autocrine loop. Cell Growth Differ 1998; 9:565-573. (Pubitemid 28345913)
30. Shields JM, Mehta H, Pruitt K et al. Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin. Mol Cell Biol 2002; 22:2304-2317. (Pubitemid 34224635)
31. Bakin AV, Rinehart C, Safina A et al. A critical role of tropomyosins in TGF-β regulation of the actin cytoskeleton and cell motility in epithelial cells. Mol Biol Cell 2004; 15:4682-4694. (Pubitemid 39299114)
32. Bharadwaj S, Prasad GL. Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells. Cancer Lett 2002; 183:205-213. (Pubitemid 34628425)
33. Zhu S, Si ML, Wu H et al. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1) J Biol Chem 2007; 282:14328-14336. (Pubitemid 47100416)
34. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65:6029-6033. (Pubitemid 40994386)
35. Roldo C, Missiaglia E, Hagan JP et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006; 24:4677-4684. (Pubitemid 46630931)
36. Si ML, Zhu S, Wu H et al. miR-21-mdiated tumor growth Oncogene 2007; 26:2799-2803.
37. Prasad SVN, Jayatilleke A, Madamanchi A et al. Protein kinase activity of phosphoinositide 3-kinase regulates beta-adrenergic receptor endocytosis. Nature Cell Biol 2005; 7:785-796. (Pubitemid 41079051)
38. Houle F, Rousseau S, Morrice N et al. Extracellular signal-regulated kinase mediates phosphorylation of tropomyosin-1 to promote cytoskeleton remodeling in response to oxidative stress: impact on membrane blebbing. Mol Biol Cell 2003; 14:1418-1432. (Pubitemid 36547411)
39. Houle F, Poirer A, Dumaresq et al. DAP kinase mediates the phosphorylation of tropomyosin-1 downstream of the ERK pathway, which regulates the formation of stress fibers in response to oxidative stress. J Cell Sci 2007; 120:3666-3677. (Pubitemid 350120958)
40. Prasad GL, Fuldner RA, Cooper HL. Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc Natl Acad Sci USA 1993; 90:7039-7043. (Pubitemid 23222384)
41. Prasad GL, Masuelli L, Raj MH et al. Suppression of src-induced transformed phenotype by expression of tropomyosin-1. Oncogene 1999; 18:2027-2031. (Pubitemid 29150090)
42. Takenaga K, Masuda A. Restoration of microfilament bundle organization in v-raf-transformed NRK cells after transduction with tropomyosin 2 cDNA. Cancer Lett 1994; 87:47-53. (Pubitemid 24352939)
43. Braverman RH, Cooper HL, Lee HS et al. Anti-oncogenic effects of tropomyosin: isoform specificity and importance of protein coding sequences. Oncogene 1996; 13:537-545. (Pubitemid 26283850)
44. Gimona M, Kazzaz J, Helfman DM. Forced expression of tropomyosin 2 or 3 in vi-Ki-ras-transformed fibroblasts results in distinct phenotypic effects. Proc Natl Acad Sci USA 1996; 93:9618-9623. (Pubitemid 26296657)
45. Janssen RAJ, Mier JW. Tropomyosin-2 cDNA lacking the 3′ untranslated region riboregulator induces growth inhibition of v-Ki-ras-transformed fibroblasts. Mol Biol Cell 1997; 8:897-908. (Pubitemid 27255029)
46. Hashimoto Y, Shindo-Okada N, Tani M et al. Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display. Cancer Res 1996; 56:5266-5271. (Pubitemid 26383046)
47. Wang FL, Wang Y, Wong WK et al. Two differentially expressed genes in normal human prostate tissue and in carcinoma. Cancer Res 1996; 56:3634-3637. (Pubitemid 26272002)
48. Yager ML, Hughes JAI, Lovicu FJ et al. British J Cancer 2003; 89:860-863.
49. Pawlak G, Helfman DM. Posttranscriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts. Mol Biol Cell 2002a; 13(1):336-347. (Pubitemid 34106079)
50. Pawlak G, Helfman DM. MEK Mediates v-Src-induced disruption of the actin cytoskeleton via inactivation of the Rho-ROCK-LIM kinase pathway. J Biol Chem 2002b; 277:26927-26933. (Pubitemid 34951702)
51. Lee S, Helfman DM. Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/ cofilin pathway. J Biol Chem 2004; 279:1885-1891. (Pubitemid 38084458)
52. Sahai E, Olson MF, Marshall CJ. Cross-talk between ras and rho signalling pathways in transformation favors proliferation and increased motility. EMBO J 2001; 20:755-766. (Pubitemid 32167640)
53. Vial E, Sahai E, Marshall CJ. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 2003; 4:67-79. (Pubitemid 36904162)
54. Amano M, Ito M, Kimura K et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 1996; 271:20246-20249. (Pubitemid 26281788)
55. Kimura K, Ito M, Amano M et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996; 273:245-248. (Pubitemid 26285892)
56. Bamburg JR. Proteins of the ADF/cofilin family:essential regulators of actin dynamics. Annu Rev Cell Dev Biol 1999; 15:185-230. (Pubitemid 32250375)
57. Lee SW, Tomasetto C, Sager R. Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad Sci USA 1991; 88:2825-2829. (Pubitemid 21916512)
58. Shah V, Bharadwaj S, Kaibuchi K et al. Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: evidence for Rho kinase pathway. Oncogene 2001; 20:2112-2121. (Pubitemid 32424005)
59. Bharadwaj S, Thanawala R, Bon G et al. Resensitization of breast cancer cells to anoikis by tropomyosin1: role of Rho-kinase-dependent cytoskeleton and adhesion. Oncogene 2005; 24:8291-8303. (Pubitemid 43250921)
60. Mahadev K, Raval G, Bharadwaj S et al. Suppression of the transformed phenotype of breast cancer by tropomyosin-1. Exp Cell Res 2002; 279:40-51.
61. Boyd J, Risinger JI, Wiseman RW et al. Regulation of microfilament organization and anchorageindependent growth by tropomyosin 1. Proc Natl Acad Sci USA 1996; 92:11534-11538. (Pubitemid 26014148)
62. Helfman DM, Pawlak G. Myosin light chain kinase and acto-myosin contractility modulate activation of the ERK cascade downstream of oncogenic Ras. J Cell Biochem 2005; 95:1069-1080. (Pubitemid 41420152)